| |
BA
|
MVD
|
|---|
|
Age (years)
|
66.1 ± 1.5
|
55.6 ± 1.6 *
|
|
Gender (%)
| | |
|
Male
|
33(39%)
|
37(46%)
|
|
Female
|
51(61%)
|
43(54%)
|
|
ASA Physical Status (%)
| | |
|
1
|
8
|
13
|
|
2
|
69
|
67
|
|
3
|
20
|
19
|
|
4
|
2
|
1
|
|
Disease Length (Years)
|
7.0 ± 0.8 (0.3 – 40)
|
5.3 ± 0.7 (0.3 – 32)
|
|
Number of Medications **
| | |
|
0
|
7
|
1
|
|
1
|
48
|
43
|
|
2
|
36
|
38
|
|
3 or >
|
11
|
19
|
|
Incidence of Pre-operative Trigger Point Injections (%)
|
13.1
|
3.8 *
|
|
Incidence of prior surgery for TN (%)
|
26
|
28
|
- * P < 0.05 compared to BA
- All data reported as mean ± SEM, ** Medications use perioperatively include: Carbemazepine, Phenytoin, Baclofen, Neurontin, Depakote) used pre-operatively (%)
